Hemophilia significantly impacts lives beyond bleeding episodes, causing absenteeism, pain, and disability. India, with the ...

According to estimates by the World Federation of Hemophilia, nearly 80% of hemophilia cases in India remain undiagnosed, ...

A bleeding disorder that many people live with, without proper care or diagnosis, World Hemophilia Day, observed on 17 April, ...

From better diagnosis to breakthrough gene therapy, India is reshaping haemophilia care with a gender-inclusive lens ...

Qfitlia (fitusiran) is the first therapy for both hemophilia A or B, with or without inhibitors, available in the United ...

In this cohort of individuals with hemophilia, the physical activity levels and step count did not significantly differ between severity phenotypes. Evidence Rating Level: 1 (Excellent) Hemophilia is ...

World Hemophilia Day 2025 is observed annually7. Candidates can refer to this post for to know more about the theme, support ...

For hemophilia B patients, frequent bleeding can easily lead to damage to joint structure and function, resulting in a high disability rate. For a long time, patients could only rely on prothrombin ...

Blood clots form to stop bleeding after injury, but sometimes they appear without warning. These clots can block blood flow, ...

Over the past Iranian calendar year, which ended on March 20, a total of 26 patients (aged 9 to 50) with hemophilia lost their lives from lack of medicines caused by sanctions, according to the ...

The FDA has recently approved two new prophylactic treatments for people with hemophilia who develop antibodies to clotting ...

Qfitlia (fitusiran), the first antithrombin-lowering therapy in hemophilia, offers consistent protection with as few as six injections a year via a prefilled pen or vial and syringe Unique ...